Here's what the brand has publicly disclosed: Compounded Semaglutide (GLP-1): Omzo describes this as a weekly injection option that the brand positions for reducing hunger, improving fullness, and supporting steady weight loss over time
Patient safety considerations : GLP-1 medications carry potential adverse effects including nausea, vomiting, diarrhoea, constipation, and rarely, pancreatitis or gallbladder disease
L., Bandera, E
However, sale as a drug, food, or dietary supplement without FDA approval is unlawful under federal law
Therefore, its continued use is recommended to see its benefits ( Supplementing with CoQ10 appears to be well tolerated by humans and have low toxicity ( In fact, participants in some studies showed no major side effects taking daily doses of 1,200 mg for 16 months ( However, if side effects appear, it is recommended to divide the daily dose into two to three smaller doses
A vendor unable or unwilling to provide batch-specific testing documentation before purchase raises immediate concerns
